Refractive Surgery News

Corneal nerve metrics start to recover 3 months after SMILE but do not reach baseline levels at 12 months postoperatively, according to a study.

When managing residual refractive error, physicians should treat the source of the problem and use the least invasive intervention possible, according to a speaker at the Real World Ophthalmology meeting.

When working with patients who are dissatisfied with their multifocal IOLs after cataract surgery, there are several factors to address before assuming the patient is visually demanding, according to a speaker.

Patient candidates may be similar, but there are situations in which SMILE or LASIK might be better suited than the other procedure, according to a presentation at the Real World Ophthalmology meeting.

By the end of 2021, we will likely see FDA approval of the first presbyopia-reversing eye drops here in the United States. Media advertising is likely to draw much public interest to our clinics. Adding to my 2019 thoughts about these medications, I’d like to make four predictions about their adoption:

Noninvasive or minimally invasive approaches may be the solution for presbyopia before the onset of age-related cataract and a way to address the increasing need to perform close-range tasks.

Presbyopia is a very common age-related process that negatively impacts visual performance and quality of life. Nearly 120 million people in the United States and 2 billion around the world are impacted by presbyopia, and with the aging population the number increases every year.

With the forthcoming FDA approval and commercialization of eye drops that improve near vision, the presbyopia market is on the cusp of a pharmaceutical revolution.

When matching a patient to an IOL before refractive cataract surgery, it is important to recognize that there is no such thing as “one size fits all,” according to a speaker at the Women in Ophthalmology Summer Symposium.

Therapeutic drops are an emerging treatment for patients with presbyopia, with at least eight companies developing products.